PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
10+ emerging markets, Japan & ANZ transition in final phase
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
Increased capability to produce medicines for challenging diseases including cancer
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Propranolol LA is a generic equivalent of Inderal LA
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)